Fig. 8.
In situ hybridization of IL-17Rh1 of IL-17E transgenic tissues.
Tissues from nontransgenic (A,C,E,G) and hIL-17E transgenic (B,D,F,H) mice. Lymph node, lung, spleen, and liver samples were hybridized in situ with a 33P-labeled anti–IL-17Rh1 riboprobe as described in “Materials and methods.” Highly increased IL-17Rh1expression in lymph nodes and areas of inflammation in the lung are indicated. Increased expression is also present in spleen and liver.
